McLaughlin Kevin F
CIK 0001214938
Director
Filings
20
Latest May 21, 2026
Issuers covered
3
Showing
20 of 20
Page 1
Track record
10 of 12 open-market trades scored (83% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 10 | 70% | +3.5% | +1.8% | +19.0% | -8.0% |
| 90 days | 10 | 80% | +2.8% | +3.1% | +22.1% | -38.0% |
| 180 days | 9 | 56% | +0.5% | +9.3% | +36.8% | -54.8% |
| 365 days | 6 | 100% | +26.8% | +24.2% | +39.4% | +13.2% |
Issuers
Companies where McLaughlin Kevin F has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VCEL | Vericel Corp | 14 | May 15, 2026 |
| IVVD | Invivyd, Inc. | 4 | May 21, 2026 |
| DBTX | Decibel Therapeutics, Inc. | 2 | Sep 25, 2023 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|